Do you consider adding a GLP-1 receptor agonist to insulin therapy in a patient with newly diagnosed LADA who has not yet progressed to insulin dependence?

Auto-immune diabetes is known to have identifiable stages of beta-cell dysfunction and demise and being able to intervene with a treatment to preserve or improve beta-cell function is one of the major areas of diabetes research. Latent auto-immune diabetes presenting in adults (LADA) at a time when ...

Latent autoimmune diabetes in adults (LADA) is a form of autoimmune diabetes that develops in adulthood and progresses more slowly than type 1 diabetes (T1D).

The symptoms of LADA are similar to those of T1D and may include polyuria, polydipsia, unexplained weight loss, and fatigue. The onset is typi...